{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:22:32Z","timestamp":1793510552741,"version":"4.5.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","award":["M0475"],"award-info":[{"award-number":["M0475"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.autrev.2023.103449","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T19:50:54Z","timestamp":1695325854000},"page":"103449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options"],"prefix":"10.1016","volume":"22","author":[{"given":"Yinxiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103449_bb0005","doi-asserted-by":"crossref","first-page":"757302","DOI":"10.3389\/fimmu.2021.757302","article-title":"Cumulative roles for Epstein-Barr virus, human endogenous retroviruses, and human herpes Virus-6 in driving an inflammatory Cascade underlying MS pathogenesis","volume":"12","author":"Meier","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0015","doi-asserted-by":"crossref","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","article-title":"Multiple sclerosis, a treatable disease","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.autrev.2023.103449_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and multiple sclerosis: a comprehensive review","volume":"7","author":"Sintzel","year":"2018","journal-title":"Neurol Ther"},{"key":"10.1016\/j.autrev.2023.103449_bb0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028944","article-title":"Lifestyle and environmental factors in multiple sclerosis","volume":"9","author":"Alfredsson","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr virus in multiple sclerosis: theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11101006","article-title":"What can we learn from sex differences in MS?","volume":"11","author":"Coyle","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420936166","article-title":"Sex effects across the lifespan in women with multiple sclerosis","volume":"13","author":"Krysko","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0045","doi-asserted-by":"crossref","first-page":"620772","DOI":"10.3389\/fneur.2021.620772","article-title":"Family planning decision making in people with multiple sclerosis","volume":"12","author":"Bonavita","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120494","article-title":"The short and long-term effects of pregnancy on multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"7","author":"McCombe","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0055","doi-asserted-by":"crossref","first-page":"e1570","DOI":"10.1212\/WNL.0000000000006382","article-title":"Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS","volume":"91","author":"Houtchens","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103449_bb0060","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.celrep.2019.09.025","article-title":"T cell repertoire dynamics during pregnancy in multiple sclerosis","volume":"29","author":"Ramien","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2023.103449_bb0065","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.4049\/jimmunol.1900611","article-title":"Pregnancy enables expansion of disease-specific regulatory T cells in an animal model of multiple sclerosis","volume":"203","author":"Engler","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0070","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1080\/15592294.2021.1982510","article-title":"CD4(+) T-cell DNA methylation changes during pregnancy significantly correlate with disease-associated methylation changes in autoimmune diseases","volume":"17","author":"Badam","year":"2022","journal-title":"Epigenetics"},{"key":"10.1016\/j.autrev.2023.103449_bb0075","series-title":"Book The research of therapeutical effect and mechanism about progesterone treating the experimental allergic encephalomyelitis","article-title":"The research of therapeutical effect and mechanism about progesterone treating the experimental allergic encephalomyelitis","author":"Hongjun","year":"2008"},{"key":"10.1016\/j.autrev.2023.103449_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113589","article-title":"Metabolomic signature in sera of multiple sclerosis patients during pregnancy","volume":"19","author":"Rossi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103449_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imm.13004","article-title":"Impact of sex hormones on immune function and multiple sclerosis development","volume":"156","author":"Ysrraelit","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2023.103449_bb0090","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.3389\/fimmu.2018.03075","article-title":"Pregnancy epigenetic signature in T helper 17 and T regulatory cells in multiple sclerosis","volume":"9","author":"Iannello","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123107","article-title":"Sex hormones as key modulators of the immune response in multiple sclerosis: A review","volume":"10","author":"Murgia","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2023.103449_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13084","article-title":"Progesterone modulates the T-cell response via glucocorticoid receptor-dependent pathways","volume":"81","author":"Hierweger","year":"2019","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0105","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1073\/pnas.1617115114","article-title":"Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy","volume":"114","author":"Engler","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2023.103449_bb0110","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/eji.202049144","article-title":"Differential effects of estradiol and progesterone on human T cell activation in vitro","volume":"51","author":"Papapavlou","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0115","series-title":"A first phenotypic and functional characterization of placental extracellular vesicles from women with multiple sclerosis, Int J Mol Sci 22","author":"Martire","year":"2021"},{"key":"10.1016\/j.autrev.2023.103449_bb0120","doi-asserted-by":"crossref","first-page":"907994","DOI":"10.3389\/fimmu.2022.907994","article-title":"Alterations of NK cell phenotype during pregnancy in multiple sclerosis","volume":"13","author":"Wisgalla","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0125","doi-asserted-by":"crossref","first-page":"12126","DOI":"10.1038\/s41598-021-91655-9","article-title":"Pregnancy-induced effects on memory B-cell development in multiple sclerosis","volume":"11","author":"Janssen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103449_bb0130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11684-020-0797-2","article-title":"Recent advances in myeloid-derived suppressor cell biology","volume":"15","author":"Yaseen","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0135","doi-asserted-by":"crossref","first-page":"12876","DOI":"10.1038\/s41598-019-48473-x","article-title":"Synthetic PreImplantation factor (sPIF) induces posttranslational protein modification and reverses paralysis in EAE mice","volume":"9","author":"Hayrabedyan","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103449_bb0140","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1038\/s41598-019-44050-4","article-title":"Enhanced remyelination during late pregnancy: involvement of the GABAergic system","volume":"9","author":"Kalakh","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103449_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2019.06.007","article-title":"Risk of relapses during pregnancy among multiple sclerosis patients","volume":"34","author":"Alroughani","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0150","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000959","article-title":"Clinical and radiologic disease activity in pregnancy and postpartum in MS","volume":"8","author":"Anderson","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103449_bb0155","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000206774","article-title":"Investigating the long-term effect of pregnancy on the course of multiple sclerosis using causal inference","volume":"100","author":"Gavoille","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103449_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.24682","article-title":"Predictors of long-term disability accrual in relapse-onset multiple sclerosis","volume":"80","author":"Jokubaitis","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0165","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1177\/13524585211057767","article-title":"Pregnancy in women with MS: impact on long-term disability accrual in a nationwide Danish Cohort","volume":"28","author":"Andersen","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0170","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/ene.13965","article-title":"Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study","volume":"26","author":"Cuello","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0175","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00415-017-8594-9","article-title":"The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations","volume":"264","author":"Pardo","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0185","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/1352458514561908","article-title":"Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis","volume":"21","author":"Checa","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2013.03.005","article-title":"Sexual disparities in the incidence and course of MS","volume":"149","author":"Bove","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-0528.1980.tb04558.x","article-title":"Maternal plasma and urinary hormone levels during and after a successful abdominal pregnancy","volume":"87","author":"France","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.autrev.2023.103449_bb0200","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2018.06.025","article-title":"Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis","volume":"392","author":"Khalid","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103449_bb0205","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/13524585211023365","article-title":"Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening","volume":"28","author":"Portaccio","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/aje\/kwy197","article-title":"Pregnancy outcomes in women with multiple sclerosis","volume":"188","author":"MacDonald","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.autrev.2023.103449_bb0215","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00415-020-09913-1","article-title":"A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project","volume":"267","author":"Lopez-Leon","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0220","article-title":"Maternal multiple sclerosis is not a risk factor for neurodevelopmental disorders in offspring","volume":"7","author":"Carta","year":"2021","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.autrev.2023.103449_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11910-018-0846-2","article-title":"Caring for women with multiple sclerosis across the lifespan","volume":"18","author":"Rankin","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.autrev.2023.103449_bb0230","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/B978-0-444-64076-5.00046-6","article-title":"Multiple sclerosis","volume":"148","author":"Cotsapas","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137080","article-title":"Risk factors from pregnancy to adulthood in multiple sclerosis outcome","volume":"23","author":"Gonzalez-Madrid","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103449_bb0240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2017.00425","article-title":"The multiple sclerosis (MS) genetic risk factors indicate both acquired and innate immune cell subsets contribute to MS pathogenesis and identify novel therapeutic opportunities","volume":"8","author":"Parnell","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.699","article-title":"Sexual dysfunction in female patients with relapsing-remitting multiple sclerosis","volume":"7","author":"Bartnik","year":"2017","journal-title":"Brain Behav"},{"key":"10.1016\/j.autrev.2023.103449_bb0250","first-page":"2","article-title":"Pregnancy and motherhood concerns surrounding women with multiple sclerosis: a qualitative content analysis","volume":"8","author":"Ghafoori","year":"2020","journal-title":"Int J Community Based Nurs Midwifery"},{"key":"10.1016\/j.autrev.2023.103449_bb0255","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1177\/1352458519865118","article-title":"Effect of assisted reproductive technology on multiple sclerosis relapses: case series and meta-analysis","volume":"26","author":"Bove","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0260","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/14656566.2020.1774554","article-title":"Pharmacotherapeutic considerations in women with multiple sclerosis","volume":"21","author":"Andersen","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.autrev.2023.103449_bb0265","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200106","article-title":"Inflammatory activity after diverse fertility treatments: a multicenter analysis in the modern multiple sclerosis treatment era","volume":"10","author":"Graham","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103449_bb0270","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.msard.2018.01.019","article-title":"Uncovering the link between reproductive factors and multiple sclerosis: a case-control study on Iranian females","volume":"20","author":"Salehi","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0275","first-page":"57","article-title":"Medroxyprogesterone acetate attenuates demyelination, modulating microglia activation, in a cuprizone neurotoxic demyelinating mouse model","volume":"10","author":"Mohammadi","year":"2021","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/j.autrev.2023.103449_bb0280","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/1352458517701314","article-title":"Contraception for women with multiple sclerosis: guidance for healthcare providers","volume":"23","author":"Houtchens","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0285","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.autrev.2023.103449_bb0290","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3389\/fimmu.2019.02954","article-title":"Multiple sclerosis and cancer: the Ying-Yang effect of disease modifying therapies","volume":"10","author":"Melamed","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0295","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0300","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211051012","article-title":"A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis","volume":"14","author":"Hellwig","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0305","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ncl.2018.09.007","article-title":"Management of demyelinating disorders in pregnancy","volume":"37","author":"Kaplan","year":"2019","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2023.103449_bb0310","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1352458515623366","article-title":"Glatiramer acetate during early pregnancy: a prospective cohort study","volume":"22","author":"Herbstritt","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0315","article-title":"Enduring clinical value of Copaxone(R) (Glatiramer acetate) in multiple sclerosis after 20 years of use","volume":"2019","author":"Wynn","year":"2019","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.autrev.2023.103449_bb0320","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-020-09762-y","article-title":"Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European interferon-beta pregnancy registry","volume":"267","author":"Hellwig","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0325","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40120-020-00201-8","article-title":"Disease-modifying drugs and family planning in people with multiple sclerosis: a consensus narrative review from the Gulf region","volume":"9","author":"Alroughani","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.autrev.2023.103449_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40265-020-01437-2","article-title":"Alemtuzumab: a review in relapsing remitting multiple sclerosis","volume":"81","author":"Syed","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.autrev.2023.103449_bb0335","doi-asserted-by":"crossref","first-page":"101961","DOI":"10.1016\/j.msard.2020.101961","article-title":"Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use","volume":"40","author":"Triplett","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0340","article-title":"Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks","volume":"90","author":"Portaccio","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103449_bb0345","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13311-022-01224-9","article-title":"Monoclonal antibodies in the treatment of relapsing multiple sclerosis: an overview with emphasis on pregnancy, vaccination, and risk management","volume":"19","author":"Krajnc","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.autrev.2023.103449_bb0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13760-018-0883-2","article-title":"Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management","volume":"118","author":"Decallonne","year":"2018","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.autrev.2023.103449_bb0355","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000913","article-title":"Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany","volume":"8","author":"Kumpfel","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103449_bb0360","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2147\/NDT.S147874","article-title":"New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab","volume":"14","author":"Frau","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.autrev.2023.103449_bb0365","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418804760","article-title":"Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure","volume":"11","author":"Geissbuhler","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0370","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.autrev.2023.103449_bb0375","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40264-020-00948-x","article-title":"Pregnancy outcomes during the clinical development program of cladribine in multiple sclerosis: an integrated analysis of safety","volume":"43","author":"Giovannoni","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.autrev.2023.103449_bb0380","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.freeradbiomed.2022.12.013","article-title":"Developmental impacts of Nrf2 activation by dimethyl fumarate (DMF) in the developing zebrafish (Danio rerio) embryo","volume":"194","author":"Marques","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40120-022-00421-0","article-title":"Multiple sclerosis in pregnancy: a commentary on disease modification and symptomatic drug therapies","volume":"12","author":"Iyer","year":"2023","journal-title":"Neurol Ther"},{"key":"10.1016\/j.autrev.2023.103449_bb0390","doi-asserted-by":"crossref","first-page":"102398","DOI":"10.1016\/j.msard.2020.102398","article-title":"Ocrelizumab exposure in the second trimester of pregnancy without neonatal B-cell depletion","volume":"45","author":"Rolfes","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0395","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11940-021-00666-4","article-title":"Treatment of women with multiple sclerosis planning pregnancy","volume":"23","author":"Krysko","year":"2021","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0400","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000903","article-title":"Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab","volume":"7","author":"Razaz","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103449_bb0405","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40120-019-00160-9","article-title":"Fingolimod rebound: a review of the clinical experience and management considerations","volume":"8","author":"Barry","year":"2019","journal-title":"Neurol Ther"},{"key":"10.1016\/j.autrev.2023.103449_bb0410","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1177\/1352458517728813","article-title":"Natalizumab during pregnancy and lactation","volume":"24","author":"Proschmann","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0415","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40120-018-0112-1","article-title":"European and American guidelines for multiple sclerosis treatment","volume":"7","author":"Ghezzi","year":"2018","journal-title":"Neurol Ther"},{"key":"10.1016\/j.autrev.2023.103449_bb0420","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40120-018-0110-3","article-title":"Practical evidence-based recommendations for patients with multiple sclerosis who want to have children","volume":"7","author":"Fragoso","year":"2018","journal-title":"Neurol Ther"},{"key":"10.1016\/j.autrev.2023.103449_bb0425","first-page":"1","article-title":"Updated perspectives on the challenges of managing multiple sclerosis during pregnancy","volume":"12","author":"Villaverde-Gonzalez","year":"2022","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"10.1016\/j.autrev.2023.103449_bb0430","doi-asserted-by":"crossref","first-page":"102703","DOI":"10.1016\/j.msard.2020.102703","article-title":"Underutilization of physical therapy for symptomatic women with MS during and following pregnancy","volume":"48","author":"Block","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0435","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1177\/13524585211005660","article-title":"Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis","volume":"27","author":"Chatterton","year":"2021","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0440","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/practneurol-2018-002060","article-title":"UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines","volume":"19","author":"Dobson","year":"2019","journal-title":"Pract Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0445","doi-asserted-by":"crossref","first-page":"e1950","DOI":"10.1212\/WNL.0000000000009371","article-title":"Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT","volume":"94","author":"Cortese","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103449_bb0450","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4103\/1673-5374.314294","article-title":"Oligodendrocyte pathology in fetal alcohol spectrum disorders","volume":"17","author":"Darbinian","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.autrev.2023.103449_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102147","article-title":"Consensus recommendations for family planning and pregnancy in multiple sclerosis in argentina","volume":"43","author":"Liguori","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0460","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.3389\/fimmu.2019.02739","article-title":"Immunomodulatory effects of vitamin D in pregnancy and beyond","volume":"10","author":"Cyprian","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0465","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.annepidem.2019.12.010","article-title":"Gestational vitamin D and offspring risk of multiple sclerosis: a systematic review and meta-analysis","volume":"43","author":"Jasper","year":"2020","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.autrev.2023.103449_bb0470","doi-asserted-by":"crossref","first-page":"105606","DOI":"10.1016\/j.jsbmb.2020.105606","article-title":"Canadian recommendations for vitamin D intake for persons affected by multiple sclerosis","volume":"199","author":"Atkinson","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.autrev.2023.103449_bb0475","article-title":"Vitamin D supplementation for women during pregnancy","volume":"7","author":"Palacios","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2023.103449_bb0480","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12884-022-04498-1","article-title":"Pregnancy planning health information and service needs of women with chronic non-communicable conditions: a systematic review and narrative synthesis","volume":"22","author":"Hammarberg","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.autrev.2023.103449_bb0485","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5694\/mja2.51012","article-title":"Vaccinations in patients with multiple sclerosis: review and recommendations","volume":"214","author":"Nesbitt","year":"2021","journal-title":"Med J Aust"},{"key":"10.1016\/j.autrev.2023.103449_bb0490","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review","volume":"264","author":"Mailand","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0495","doi-asserted-by":"crossref","DOI":"10.1177\/13524585221150881","article-title":"Safety of COVID-19 vaccines in multiple sclerosis: a systematic review and meta-analysis","author":"Stefanou","year":"2023","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0500","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/practneurol-2020-002527","article-title":"Protecting people with multiple sclerosis through vaccination","volume":"20","author":"Reyes","year":"2020","journal-title":"Pract Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0505","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.nrl.2020.02.006","article-title":"Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement","volume":"36","author":"Otero-Romero","year":"2021","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.autrev.2023.103449_bb0510","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajog.2021.08.054","article-title":"An update on COVID-19 and pregnancy","volume":"226","author":"Jamieson","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2023.103449_bb0515","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000890","article-title":"MRI activity in MS and completed pregnancy: Data from a tertiary academic center","volume":"7","author":"Houtchens","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103449_bb0520","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2016.12126","article-title":"Association between MRI exposure during pregnancy and fetal and childhood outcomes","volume":"316","author":"Ray","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.autrev.2023.103449_bb0525","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1148\/radiol.2020191550","article-title":"Specific absorption rate and specific energy dose: comparison of 1.5-T versus 3.0-T fetal MRI","volume":"295","author":"Barrera","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2023.103449_bb0530","article-title":"Pregnancy and multiple sclerosis: An update on the disease modifying treatment strategy and a review of Pregnancy\u2019s impact on disease activity","volume":"56","author":"Varyte","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.autrev.2023.103449_bb0535","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jmri.28086","article-title":"Gadolinium retention in the brain of mother and pup mouse: effect of pregnancy and repeated administration of gadolinium-based contrast agents","volume":"56","author":"Yao","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.autrev.2023.103449_bb0540","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0545","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(18)30029-9","article-title":"Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model","volume":"6","author":"Bearak","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.autrev.2023.103449_bb0550","doi-asserted-by":"crossref","first-page":"268","DOI":"10.36740\/WLek202201221","article-title":"Preterm detection of congenital anomalies by ultrasound and correlation with possible associated risk factors","volume":"75","author":"Mahdi","year":"2022","journal-title":"Wiad Lek"},{"key":"10.1016\/j.autrev.2023.103449_bb0555","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5694\/mja2.50113","article-title":"Family planning, antenatal and post partum care in multiple sclerosis: a review and update","volume":"211","author":"Van Der Walt","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.autrev.2023.103449_bb0560","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/1352458520912637","article-title":"Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis","volume":"27","author":"Demortiere","year":"2021","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0565","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.msard.2019.04.003","article-title":"Management strategies for female patients of reproductive potential with multiple sclerosis: an evidence-based review","volume":"32","author":"Coyle","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0570","first-page":"240","article-title":"The clinical use of corticosteroids in pregnancy","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.autrev.2023.103449_bb0575","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.rbmo.2020.01.013","article-title":"Live birth in women with multiple sclerosis receiving assisted reproduction","volume":"40","author":"Jolving","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.autrev.2023.103449_bb0580","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bcpt.12367","article-title":"Use of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriage","volume":"116","author":"Bjorn","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.autrev.2023.103449_bb0585","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10072-017-3081-8","article-title":"Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach","volume":"38","author":"Amato","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2023.103449_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8101623","article-title":"Therapeutic apheresis in acute relapsing multiple sclerosis: current evidence and unmet needs-a systematic review","volume":"8","author":"Rolfes","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0595","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418774973","article-title":"Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica","volume":"11","author":"Hoffmann","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0600","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012192","article-title":"The association between urinary tract infection during pregnancy and preeclampsia: a meta-analysis","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103449_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102462","article-title":"Urinary tract infection in patients with multiple sclerosis: an overview","volume":"46","author":"Medeiros Junior","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0610","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/aogs.14473","article-title":"New insights into smoking and urinary tract infections during pregnancy using pregnancy-pair design: a population-based register study","volume":"102","author":"Wallin","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.autrev.2023.103449_bb0615","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013198","article-title":"Prevalence of undiagnosed asymptomatic bacteriuria and associated risk factors during pregnancy: a cross-sectional study at two tertiary centres in Cairo, Egypt","volume":"7","author":"Abdel-Aziz Elzayat","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2023.103449_bb0620","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/21556660.2020.1721507","article-title":"Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations","volume":"9","author":"Canibano","year":"2020","journal-title":"J Drug Assess"},{"key":"10.1016\/j.autrev.2023.103449_bb0625","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3389\/fimmu.2018.01257","article-title":"Gestational hypothyroxinemia affects its offspring with a reduced suppressive capacity impairing the outcome of the experimental autoimmune encephalomyelitis","volume":"9","author":"Haensgen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0630","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000500881","article-title":"2019 European thyroid association guidelines on the management of thyroid dysfunction following immune reconstitution therapy","volume":"8","author":"Muller","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.autrev.2023.103449_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207722","article-title":"Increased pro-thrombotic platelet activity associated with thrombin\/PAR1-dependent pathway disorder in patients with secondary progressive multiple sclerosis","volume":"21","author":"Dziedzic","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2023.103449_bb0640","doi-asserted-by":"crossref","first-page":"101423","DOI":"10.1016\/j.msard.2019.101423","article-title":"Incident cardiovascular disease in patients diagnosed with multiple sclerosis: a multi-database study","volume":"37","author":"Persson","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0645","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/a-1717-7663","article-title":"Thrombophilia, thrombosis and Thromboprophylaxis in pregnancy: for what and in whom?","volume":"42","author":"Middeldorp","year":"2022","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.autrev.2023.103449_bb0650","doi-asserted-by":"crossref","first-page":"1011206","DOI":"10.3389\/fmed.2022.1011206","article-title":"Case report: successful thromboprophylaxis with enoxaparin in a pregnant woman with internal jugular vein agenesis","volume":"9","author":"Di Micco","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103449_bb0655","doi-asserted-by":"crossref","first-page":"e2789","DOI":"10.1212\/WNL.0000000000012062","article-title":"Perinatal depression and anxiety in women with multiple sclerosis: a population-based cohort study","volume":"96","author":"Eid","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103449_bb0660","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s42000-020-00197-8","article-title":"Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications","volume":"19","author":"Anagnostouli","year":"2020","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.autrev.2023.103449_bb0665","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3949\/ccjm.87a.19054","article-title":"Perinatal depression: a review","volume":"87","author":"Van Niel","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.autrev.2023.103449_bb0670","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/1028415X.2022.2031494","article-title":"Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials","volume":"26","author":"Borges-Vieira","year":"2023","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.autrev.2023.103449_bb0675","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hup.2451","article-title":"Serotonin reuptake inhibitors and breastfeeding: a systematic review","volume":"30","author":"Orsolini","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.autrev.2023.103449_bb0680","doi-asserted-by":"crossref","first-page":"102746","DOI":"10.1016\/j.msard.2021.102746","article-title":"Multiple sclerosis does not affect the muscular strength of the pelvic floor during pregnancy a case control study","volume":"49","author":"Lourenco","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0685","article-title":"Cesarean section in women with MS: A choice or a need?","volume":"38","author":"De Giglio","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0690","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/CPJ.0000000000000436","article-title":"Multiple sclerosis management and reproductive changes: a guide for general neurologists","volume":"8","author":"Kaisey","year":"2018","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.autrev.2023.103449_bb0695","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1082","article-title":"Obstetric anesthesia\/analgesia does not affect disease course in multiple sclerosis: 10-year retrospective cohort study","volume":"8","author":"Harazim","year":"2018","journal-title":"Brain Behav"},{"key":"10.1016\/j.autrev.2023.103449_bb0700","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1352458518763080","article-title":"Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS","volume":"25","author":"Lavie","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0705","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.semperi.2014.07.004","article-title":"Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist","volume":"38","author":"Hopkins","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.autrev.2023.103449_bb0710","doi-asserted-by":"crossref","first-page":"642038","DOI":"10.3389\/fimmu.2021.642038","article-title":"Effector T helper cells are selectively controlled during pregnancy and related to a postpartum relapse in multiple sclerosis","volume":"12","author":"Koetzier","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0715","doi-asserted-by":"crossref","first-page":"102518","DOI":"10.1016\/j.msard.2020.102518","article-title":"Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: a retrospective registry study","volume":"46","author":"Villaverde-Gonzalez","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2023.103449_bb0720","doi-asserted-by":"crossref","first-page":"766956","DOI":"10.3389\/fneur.2021.766956","article-title":"Estimating risk of multiple sclerosis disease reactivation in pregnancy and postpartum: the VIPRiMS score","volume":"12","author":"Bsteh","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0725","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012084","article-title":"Natalizumab, fingolimod and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis","volume":"96","author":"Yeh","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103449_bb0730","article-title":"Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: a prospective analysis","volume":"9","author":"Menascu","year":"2023","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.autrev.2023.103449_bb0735","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cns.12985","article-title":"Intravenous immunoglobulin treatment in multiple sclerosis: a prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period","volume":"25","author":"Winkelmann","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.autrev.2023.103449_bb0740","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1007\/s00415-022-11215-7","article-title":"COPP-MS: COrticosteroids during the post-partum in relapsing multiple sclerosis patients","volume":"269","author":"Leguy","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0745","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1212\/WNL.0000000000004207","article-title":"Breastfeeding, ovulatory years, and risk of multiple sclerosis","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2023.103449_bb0750","doi-asserted-by":"crossref","first-page":"1090133","DOI":"10.3389\/fneur.2022.1090133","article-title":"The protective role of breastfeeding in multiple sclerosis: latest evidence and practical considerations","volume":"13","author":"Collorone","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0755","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12778","article-title":"Breastfeeding and autoimmunity: Programing health from the beginning","volume":"79","author":"Vieira Borba","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0760","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1177\/1352458517717806","article-title":"Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis","volume":"24","author":"Boz","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0765","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0890334415570970","article-title":"Transfer of methylprednisolone into breast milk in a mother with multiple sclerosis","volume":"31","author":"Cooper","year":"2015","journal-title":"J Hum Lact"},{"key":"10.1016\/j.autrev.2023.103449_bb0770","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000757","article-title":"Safety of potential breast milk exposure to IFN-beta or glatiramer acetate: one-year infant outcomes","volume":"7","author":"Ciplea","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103449_bb0775","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1177\/13524585221083982","article-title":"Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis - COBRA study","volume":"28","author":"Ciplea","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0780","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715195","article-title":"Drug and neurofilament levels in serum and breastmilk of women with multiple sclerosis exposed to natalizumab during pregnancy and lactation","volume":"12","author":"Proschmann","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103449_bb0785","article-title":"Pregnancy outcome following exposure to ocrelizumab in multiple sclerosis","volume":"8","author":"Chey","year":"2022","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.autrev.2023.103449_bb0790","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0890334414566237","article-title":"Transfer of natalizumab into breast milk in a mother with multiple sclerosis","volume":"31","author":"Baker","year":"2015","journal-title":"J Hum Lact"},{"key":"10.1016\/j.autrev.2023.103449_bb0795","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000723","article-title":"Monoclonal antibody treatment during pregnancy and\/or lactation in women with MS or neuromyelitis optica spectrum disorder","volume":"7","author":"Ciplea","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2023.103449_bb0800","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/1352458519830588","article-title":"Breastfeeding and post-partum relapses in multiple sclerosis patients","volume":"25","author":"Portaccio","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.autrev.2023.103449_bb0805","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.851413","article-title":"Disease-modifying drugs and breastfeeding in multiple sclerosis: a narrative literature review","volume":"13","author":"Capone","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2023.103449_bb0810","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1586\/ern.13.12","article-title":"Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance","volume":"13","author":"Lu","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.autrev.2023.103449_bb0815","first-page":"1034912","article-title":"Pregnancy and the use of disease-modifying therapies in patients with multiple sclerosis: benefits versus risks","volume":"2016","author":"Alroughani","year":"2016","journal-title":"Mult Scler Int"},{"key":"10.1016\/j.autrev.2023.103449_bb0820","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/CON.0000000000000328","article-title":"Pregnancy in the setting of multiple sclerosis","volume":"22","author":"Fabian","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.autrev.2023.103449_bb0825","series-title":"Book U.S. Food and Drug Administration \u2013 FDA","author":"U.S. Food and Drug Administration \u2013 FDA","year":"2023"},{"key":"10.1016\/j.autrev.2023.103449_bb0830","series-title":"Book The European Medicines Agency - EMA","article-title":"Rebif. Summary of product characteristics. (Online)","author":"The European Medicines Agency - EMA","year":"2023"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:29:28Z","timestamp":1761600568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":166,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1568997223001830"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103449","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103449"}}